Ignite Creation Date:
2025-12-24 @ 3:44 PM
Ignite Modification Date:
2026-05-15 @ 2:45 AM
Study NCT ID:
NCT06282692
Status:
RECRUITING
Last Update Posted:
2024-02-28
First Post:
2023-06-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old
Sponsor:
Dr. Soetomo General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
UNAIR-MP-INAKTIF-R-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None